Published in Genet Med on April 01, 2005
Acceptance of genetic testing for hereditary breast ovarian cancer among study enrollees from an African American kindred. Am J Med Genet A (2006) 1.32
Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes. Psychooncology (2009) 1.17
Public perspectives about pharmacogenetic testing and managing ancillary findings. Genet Test Mol Biomarkers (2011) 1.11
Psychosocial determinants of intention to screen for Alzheimer's disease. Alzheimers Dement (2007) 0.96
Association between temporal orientation and attitudes about BRCA1/2 testing among women of African descent with family histories of breast cancer. Patient Educ Couns (2008) 0.92
Effect of genetic counseling and testing for BRCA1 and BRCA2 mutations in African American women: a randomized trial. Public Health Genomics (2010) 0.92
Donation intentions for cancer genetics research among African Americans. Genet Test Mol Biomarkers (2012) 0.91
Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk. Genet Med (2011) 0.90
Intentions to donate to a biobank in a national sample of African Americans. Public Health Genomics (2014) 0.87
Perceptions about genetic testing for the susceptibility to alcohol dependence and other multifactorial diseases. Genet Test Mol Biomarkers (2011) 0.84
Psychosocial approaches to participation in BRCA1/2 genetic risk assessment among African American women: a systematic review. J Community Genet (2013) 0.83
Knowledge and accuracy of perceived personal risk in underserved women who are at increased risk of breast cancer. J Cancer Educ (2010) 0.82
Genetic testing and counseling for hereditary neurological diseases in Mali. J Community Genet (2011) 0.80
Genetic testing for the susceptibility to alcohol dependence: interest and concerns in an African American population. Genet Test Mol Biomarkers (2014) 0.79
Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system. Genet Med (2014) 0.79
Utilization of religious coping strategies among African American women at increased risk for hereditary breast and ovarian cancer. Fam Community Health (2009) 0.79
African American women's limited knowledge and experiences with genetic counseling for hereditary breast cancer. J Genet Couns (2013) 0.78
African American women's perspectives on breast cancer: implications for communicating risk of basal-like breast cancer. J Health Care Poor Underserved (2013) 0.76
Conducting Precision Medicine Research with African Americans. PLoS One (2016) 0.75
Beliefs and Preferences for Medical Research Among African-Americans. J Racial Ethn Health Disparities (2015) 0.75
Assessing risk for Mendelian disorders in a Bronx population. Mol Genet Genomic Med (2017) 0.75
Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol (2004) 3.88
Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med (2010) 2.94
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther (2006) 2.49
Smoking cessation treatment by primary care physicians: An update and call for training. Am J Prev Med (2006) 2.36
Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience. Contemp Clin Trials (2008) 2.29
Differences in the patterns of health care system distrust between blacks and whites. J Gen Intern Med (2008) 2.20
Does delay discounting play an etiological role in smoking or is it a consequence of smoking? Drug Alcohol Depend (2009) 2.15
Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci (2007) 2.11
Barriers of and facilitators to physician recommendation of colorectal cancer screening. J Gen Intern Med (2007) 2.05
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology (2006) 1.93
Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav (2008) 1.90
Trust, benefit, satisfaction, and burden: a randomized controlled trial to reduce cancer risk through African-American churches. J Gen Intern Med (2003) 1.84
The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics (2006) 1.83
Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ (2010) 1.77
Expanding the obesity research paradigm to reach African American communities. Prev Chronic Dis (2007) 1.71
Applying a behavioral economic framework to understanding adolescent smoking. Psychol Addict Behav (2004) 1.61
Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res (2004) 1.59
Racial differences in quality of life following prostate cancer diagnosis. Urology (2010) 1.51
Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry (2004) 1.50
The efficacy of motivational interviewing versus brief advice for adolescent smoking behavior change. Pediatrics (2011) 1.48
Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship. Infect Control Hosp Epidemiol (2014) 1.45
Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry (2010) 1.38
Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. Genet Med (2006) 1.34
Community health worker intervention to decrease cervical cancer disparities in Hispanic women. J Gen Intern Med (2010) 1.33
Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol (2003) 1.32
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci U S A (2011) 1.29
Genetics, epidemiology, and cancer disparities: is it black and white? J Clin Oncol (2006) 1.27
Recruiting African American women to participate in hereditary breast cancer research. J Clin Oncol (2005) 1.25
Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev (2005) 1.24
Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine Tob Res (2004) 1.24
Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2010) 1.19
Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biol Psychiatry (2006) 1.18
Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women. Patient Educ Couns (2006) 1.17
Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology (2010) 1.17
Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy. Photochem Photobiol Sci (2009) 1.17
Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics (2002) 1.13
Knowledge about genetics among African Americans. J Genet Couns (2007) 1.13
Relapse dynamics during smoking cessation: recurrent abstinence violation effects and lapse-relapse progression. J Abnorm Psychol (2011) 1.12
Effect of team sport participation on genetic predisposition to adolescent smoking progression. Arch Gen Psychiatry (2006) 1.12
Identification of pharmacogenetic markers in smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet (2008) 1.12
Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer (2009) 1.11
Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. J Subst Abuse Treat (2007) 1.08
Diffusion of an evidence-based smoking cessation intervention through Facebook: a randomised controlled trial study protocol. BMJ Open (2014) 1.07
Predictors of participation in a smoking cessation program among young adult smokers. Cancer Epidemiol Biomarkers Prev (2007) 1.06
Developing an academic-community partnership for research in prostate cancer. J Cancer Educ (2006) 1.05
Intentions to participate in genetics research among African American smokers. Cancer Epidemiol Biomarkers Prev (2006) 1.04
Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay. Cancer Res (2014) 1.03
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients. Clin Cancer Res (2004) 1.03
Participation rates and representativeness of African Americans recruited to a health promotion program. Health Educ Res (2009) 1.01
Isoniazid-resistant tuberculous meningitis, United States, 1993-2005. Emerg Infect Dis (2011) 1.01
A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Control (2010) 0.99
Modeling smoking cessation data with alternating states and a cure fraction using frailty models. Stat Med (2010) 0.99
Genetic testing for colon cancer among African-Americans in North Carolina. Prev Med (2005) 0.99
Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen. Cancer Res (2002) 0.98
Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev (2006) 0.98
A placebo-controlled trial of modafinil for nicotine dependence. Drug Alcohol Depend (2008) 0.98
Effects of different nicotine replacement therapies on postcessation psychological responses. Addict Behav (2005) 0.98
Changes in food reward following smoking cessation: a pharmacogenetic investigation. Psychopharmacology (Berl) (2004) 0.97
Low rates of African American participation in genetic counseling and testing for BRCA1/2 mutations: racial disparities or just a difference? J Genet Couns (2012) 0.97
Cultural, economic, and psychological predictors of colonoscopy in a national sample. J Gen Intern Med (2011) 0.97
Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem Photobiol (2003) 0.97
Age-related differences in working memory deficits during nicotine withdrawal. Addict Biol (2013) 0.96
Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate. Radiat Res (2010) 0.95
Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers. Nicotine Tob Res (2011) 0.95
Perceptions of changes in weight among African American breast cancer survivors. Psychooncology (2006) 0.94
Predictors of enrollment in a smoking cessation clinical trial after eligibility screening. J Natl Med Assoc (2009) 0.94
Using a mixed-methods approach to identify health concerns in an African American community. Am J Public Health (2011) 0.94
Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns? J Clin Oncol (2011) 0.94
Breast cancer screening behaviors among African American women with a strong family history of breast cancer. Prev Med (2006) 0.93
High payload delivery of optical imaging and photodynamic therapy agents to tumors using phthalocyanine-reconstituted low-density lipoprotein nanoparticles. J Biomed Opt (2005) 0.93
Young adult smoking: what factors differentiate ex-smokers, smoking cessation treatment seekers and nontreatment seekers? Addict Behav (2009) 0.93
Effect of photosensitizer dose on fluence rate responses to photodynamic therapy. Photochem Photobiol (2007) 0.93
The influence of health care policies and health care system distrust on willingness to undergo genetic testing. Med Care (2012) 0.92
Understanding participation by African Americans in cancer genetics research. J Natl Med Assoc (2012) 0.92
Digital image analysis of cigarette filter stains as an indicator of compensatory smoking. Cancer Epidemiol Biomarkers Prev (2006) 0.92
Increase in anger symptoms after smoking cessation predicts relapse. Drug Alcohol Depend (2008) 0.91
Nicotine abstinence-induced cerebral blood flow changes by genotype. Neurosci Lett (2008) 0.91
Why do those who request smoking treatment fail to attend the first appointment? J Subst Abuse Treat (2007) 0.91
Donation intentions for cancer genetics research among African Americans. Genet Test Mol Biomarkers (2012) 0.91
Differences in cultural beliefs and values among African American and European American men with prostate cancer. Cancer Control (2007) 0.89
Sociocultural predictors of breast cancer risk perceptions in African American breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2007) 0.88
Retention of African American women in cancer genetics research. Am J Med Genet A (2008) 0.88
Tumor vascular microenvironment determines responsiveness to photodynamic therapy. Cancer Res (2012) 0.88
Experiences with weight change in African-American breast cancer survivors. Breast J (2008) 0.88